Meeting
2018 ASCO Annual Meeting
Limited stage nodular lymphocyte predominant Hodgkin lymphoma (NLPHL): A subgroup analysis of the HD.6 clinical trial.
Authors
Bethany Monteith
Queen's University, Kingston, ON, CA
Bethany Monteith , Erica C. DiMaria , Michael Crump , Jeffrey B. Ames , Jane N. Winter , Marina Djurfeldt , Lois E. Shepherd , Ralph M. Meyer , Bingshu E. Chen , Annette E. Hay
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Track
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Sub Track
Hodgkin Lymphoma
Clinical Trial Registration Number
NCT 00002561
Citation
J Clin Oncol 36, 2018 (suppl; abstr 7535)
DOI
10.1200/JCO.2018.36.15_suppl.7535
Abstract #
7535
Poster Bd #
172
Abstract Disclosures
Similar Posters
Poster
2012 ASCO Annual Meeting
Intensive alternating 6-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma in children and adolescents: Impact on survival.
First Author: Gerges Attia Demian
Poster
2023 ASCO Annual Meeting
A single-arm, multi-institutional, phase 2 study of a pembrolizumab-based organ preservation strategy for locally advanced larynx cancers: SMART-KEY (LACOG 0720) trial.
First Author: Thiago Bueno Oliveira Sr.
Poster
2022 ASCO Annual Meeting
Sequential treatment with gemcitabine/nab-paclitaxel (GA) and FOLFIRINOX (FFX) followed by stereotactic MRI-guided adaptive radiation therapy (SMART) in patients with locally advanced pancreatic cancer (LAPC): GABRINOX-ART phase 2, multicenter trial.
First Author: Fabienne Portales
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Hypofractionated radiotherapy to the pancreas: U.K. experience.
First Author: Suliana Teoh